Chiron Capital Management’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-3,000
Closed -$224K – 128
2025
Q2
$224K Buy
3,000
+700
+30% +$55K 0.19% 109
2025
Q1
$203K Hold
2,300
– – 0.18% 107
2024
Q4
$210K Sell
2,300
-30
-1% -$3.08K 0.2% 107
2024
Q3
$261K Hold
2,330
– – 0.23% 94
2024
Q2
$228K Sell
2,330
-300
-11% -$29.8K 0.22% 100
2024
Q1
$264K Sell
2,630
-500
-16% -$44K 0.24% 89
2023
Q4
$281K Buy
+3,130
New +$249K 0.24% 93
2020
Q4
– Sell
-530
Closed -$41K – 182
2020
Q3
$41K Buy
+530
New +$39.9K 0.03% 171

Other funds holding EMN

Chiron Capital Management's EMN Position: Q3 2025 in Review

Chiron Capital Management sold out of Eastman Chemical (EMN) in Q3 2025, closing a stake of 3,000 shares — an estimated $224K sold.

Chiron Capital Management first reported a position in EMN in Q3 2020 and held it in 8 quarters. The position peaked at $281K in Q4 2023. 664 funds tracked by Wall St. Rank hold EMN as of Q3 2025.

  • Chiron Capital Management reported no remaining Eastman Chemical position as of Q3 2025 after selling out during the quarter.
  • Chiron Capital Management sold 3,000 Eastman Chemical shares in Q3 2025, an estimated $224K.
  • Chiron Capital Management first reported a position in Eastman Chemical in Q3 2020 and held it in 8 quarters.
  • Chiron Capital Management's Eastman Chemical position peaked at $281K in Q4 2023.
  • 664 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2025.

Based on Chiron Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.